Cargando…

Keep the quality high: the benefits of lot testing for the quality control of malaria rapid diagnostic tests

BACKGROUND: The production and use of malaria rapid diagnostic tests (RDTs) has risen dramatically over the past 20 years. In view of weak or non-existing in vitro diagnostics (IVD) regulations and post-marketing surveillance (PMS) systems in malaria endemic countries, the World Health Organization,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Incardona, Sandra, Bell, David, Campillo, Ana, Cunningham, Jane, Ariey, Frederic, Fandeur, Thierry, Luchavez, Jennifer, Luna, Christian Anthony, Ménard, Didier, Nhem, Sina, Sornillo, Johanna Beulah, Witkowski, Benoit, Katz, Zachary, Dittrich, Sabine, Ding, Xavier C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359453/ https://www.ncbi.nlm.nih.gov/pubmed/32660630 http://dx.doi.org/10.1186/s12936-020-03324-3

Ejemplares similares

A review of the WHO malaria rapid diagnostic test product testing programme (2008–2018): performance, procurement and policy
por: Cunningham, Jane, et al.
Publicado: (2019)

Malaria rapid diagnostic test as point-of-care test: study protocol for evaluating the VIKIA® Malaria Ag Pf/Pan
por: Kim, Saorin, et al.
Publicado: (2015)

Circulating antibodies against Plasmodium falciparum histidine-rich proteins 2 interfere with antigen detection by rapid diagnostic tests
por: Ho, Mei-Fong, et al.
Publicado: (2014)

Large-scale malaria survey in Cambodia: Novel insights on species distribution and risk factors
por: Incardona, Sandra, et al.
Publicado: (2007)

Lots of Lovely Numbers, but Why Does Everyone Make It So Difficult?
por: Pullinger, John
Publicado: (2020)

Economic considerations support C-reactive protein testing alongside malaria rapid diagnostic tests to guide antimicrobial therapy for patients with febrile illness in settings with low malaria endemicity
por: Lubell, Yoel, et al.
Publicado: (2019)

Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests
por: Baker, Joanne, et al.
Publicado: (2010)

Assuring the quality of diagnostic testing: The future is now
por: Nkengsong, John, et al.
Publicado: (2016)

Global survey of malaria rapid diagnostic test (RDT) sales, procurement and lot verification practices: assessing the use of the WHO–FIND Malaria RDT Evaluation Programme (2011–2014)
por: Incardona, Sandra, et al.
Publicado: (2017)

External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations
por: Ji, Hezhao, et al.
Publicado: (2020)

When to keep it simple – adaptive designs are not always useful
por: Wason, James M. S., et al.
Publicado: (2019)

Face masks and nanotechnology: Keep the blue side up
por: Palmieri, Valentina, et al.
Publicado: (2021)

Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines
por: Espino, Fe Esperanza, et al.
Publicado: (2016)

Keep It Simple: Using README Files to Advance Standardization in Chronobiology
por: Zieliński, Tomasz, et al.
Publicado: (2023)

Database archiving: how to keep lots of data for a very long time
por: Olson, Jack E
Publicado: (2008)

Adapting Lot Quality Assurance Sampling to accommodate imperfect diagnostic tests: application to COVID-19 serosurveillance in Haiti
por: Fulcher, Isabel R., et al.
Publicado: (2022)

WHO malaria nucleic acid amplification test external quality assessment scheme: results of distribution programmes one to three
por: Cunningham, Jane A., et al.
Publicado: (2020)

The real cost of sequencing: scaling computation to keep pace with data generation
por: Muir, Paul, et al.
Publicado: (2016)

Characterization of specimens for quality control of malaria rapid diagnostic tests: what is the best indicator for performance?
por: Rees-Channer, Roxanne, et al.
Publicado: (2014)

How to keep good clinical records
por: Mathioudakis, Alexander, et al.
Publicado: (2016)

How the Glasgow Declaration on Forests can help keep alive the 1.5 °C target
por: Gasser, Thomas, et al.
Publicado: (2022)

Performance of the CareStart™ G6PD Deficiency Screening Test, a Point-of-Care Diagnostic for Primaquine Therapy Screening
por: Kim, Saorin, et al.
Publicado: (2011)

Direct-to-consumer genetic testing
por: Kim, Jong-Won
Publicado: (2019)

Population-based norms of the Life Orientation Test–Revised (LOT-R)
por: Schou-Bredal, Inger, et al.
Publicado: (2017)

A proposal for a primary screening tool: ‘Keep your waist circumference to less than half your height’
por: Ashwell, Margaret, et al.
Publicado: (2014)

Their Lot
por: Garrod, Pat
Publicado: (1965)

Quality Controls in Ligand Binding Assays: Recommendations and Best Practices for Preparation, Qualification, Maintenance of Lot to Lot Consistency, and Prevention of Assay Drift
por: Azadeh, Mitra, et al.
Publicado: (2019)

Scientific Hypothesis-Testing Strengthens Neuroscience Research
por: Alger, Bradley E.
Publicado: (2020)

Direct-to-consumer genetic testing: advantages and pitfalls
por: Oh, Bermseok
Publicado: (2019)

Factor structure of the Spanish version of the Life Orientation Test-Revised (LOT-R): Testing several models
por: Cano-García, Francisco J., et al.
Publicado: (2015)

The carbon‐quality temperature hypothesis: Fact or artefact?
por: Liáng, Lìyǐn L., et al.
Publicado: (2022)

The challenges of COVID-19 testing in Africa: the Ethiopian experience
por: Mulu, Andargachew, et al.
Publicado: (2021)

Understanding Laboratory Testing for SARS-CoV-2
por: Cheema, Ritu, et al.
Publicado: (2021)

Improving data quality and supervision of antiretroviral therapy sites in Malawi: an application of Lot Quality Assurance Sampling
por: Hedt-Gauthier, Bethany L, et al.
Publicado: (2012)

Discussions on the quality of antibodies are no reason to ban animal immunization
por: Custers, René, et al.
Publicado: (2020)

Quality of Life in Low-Risk MDS: An Undervalued Endpoint
por: Heyrman, Bert
Publicado: (2022)

Lot-to-Lot Variance in Immunoassays—Causes, Consequences, and Solutions
por: Luo, Yunyun, et al.
Publicado: (2023)

Choosing a Cluster Sampling Design for Lot Quality Assurance Sampling Surveys
por: Hund, Lauren, et al.
Publicado: (2015)

Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling
por: Ginting, Franciscus, et al.
Publicado: (2019)

Review of Lot Quality Assurance Sampling, Methodology and its Application in Public Health
por: Rath, Rama Shankar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_csruq1iiotk33e66qhe8887pqo